ArticleInvestigational new drugs2015

A phase I trial of mFOLFOX6 combined with the oral PI3K inhibitor BKM120 in patients with advanced refractory solid tumors.

Autumn J McRee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.